PSYCHEMEDICS CORPORATION CMN - COM (PMD)

CUSIP: 744375205

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / COM
Total 13F shares
1,397,701
Share change
-14,094
Total reported value
$7,339,631
Price per share
$5.25
Number of holders
20
Value change
-$73,851
Number of buys
4
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 744375205?
CUSIP 744375205 identifies PMD - PSYCHEMEDICS CORPORATION CMN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PSYCHEMEDICS CORPORATION CMN - COM (PMD) as of Q1 2023

As of 31 Mar 2023, PSYCHEMEDICS CORPORATION CMN - COM (PMD) was held by 20 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,397,701 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, CRAWFORD INVESTMENT COUNSEL INC, VANGUARD GROUP INC, RBF Capital, LLC, Ancora Advisors, LLC, BlackRock Inc., CANNELL CAPITAL LLC, DIMENSIONAL FUND ADVISORS LP, WEALTH EFFECTS LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 20 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.